These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 1906585

  • 1. Metabolism of 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers.
    Walovitch RC, Franceschi M, Picard M, Cheesman EH, Hall KM, Makuch J, Watson MW, Zimmerman RE, Watson AD, Ganey MV.
    Neuropharmacology; 1991 Mar; 30(3):283-92. PubMed ID: 1906585
    [Abstract] [Full Text] [Related]

  • 2. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans.
    Léveillé J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC.
    J Nucl Med; 1989 Nov; 30(11):1902-10. PubMed ID: 2809757
    [Abstract] [Full Text] [Related]

  • 3. Importance of the two ester functions for the brain retention of 99mTc-labelled ethylene dicysteine diethyl ester (99mTc-ECD).
    Vanbilloen HP, Cleynhens BJ, Verbruggen AM.
    Nucl Med Biol; 1998 Aug; 25(6):569-75. PubMed ID: 9751425
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.
    Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan RA, Goldsmith SJ.
    J Nucl Med; 1989 May; 30(5):599-604. PubMed ID: 2497233
    [Abstract] [Full Text] [Related]

  • 5. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates.
    Walovitch RC, Hill TC, Garrity ST, Cheesman EH, Burgess BA, O'Leary DH, Watson AD, Ganey MV, Morgan RA, Williams SJ.
    J Nucl Med; 1989 Nov; 30(11):1892-901. PubMed ID: 2809756
    [Abstract] [Full Text] [Related]

  • 6. [Phase I clinical study of 99mTc-ECD].
    Kubo A, Nakamura K, Tsukatani Y, Sanmiya T, Shimizu S, Yokoyama K, Hashimoto S, Torizuka K.
    Kaku Igaku; 1992 Aug; 29(8):1019-27. PubMed ID: 1434082
    [Abstract] [Full Text] [Related]

  • 7. [Metabolism of 99mTc-ethyl cysteinate dimer (99mTc-ECD) in blood--mainly in vitro].
    Inoue Y, Momose T, Amo K, Ohtake T, Watanabe T, Kosaka N, Nishikawa J, Sasaki Y.
    Kaku Igaku; 1992 Aug; 29(8):955-62. PubMed ID: 1434085
    [Abstract] [Full Text] [Related]

  • 8. Studies of the retention mechanism of the brain perfusion imaging agent 99mTc-bicisate (99mTc-ECD).
    Walovitch RC, Cheesman EH, Maheu LJ, Hall KM.
    J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S4-11. PubMed ID: 8263070
    [Abstract] [Full Text] [Related]

  • 9. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
    Léveillé J, Demonceau G, Walovitch RC.
    J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of technetium-99m-L,L-ethyl cysteinate dimer in rat and cynomolgus monkey tissue.
    Inoue Y, Momose T, Ohtake T, Nishikawa J, Sasaki Y, Waritani T, Inoue M.
    J Nucl Med; 1997 Nov; 38(11):1731-7. PubMed ID: 9374342
    [Abstract] [Full Text] [Related]

  • 11. [A fundamental study of 99mTc-ethyl cysteinate dimer (99mTc-ECD)].
    Mimura H, Ono S, Yanagimoto S, Tomomitsu T, Nishimura F, Muranaka A, Morita K, Nagai K, Otsuka N, Fukunaga M.
    Kaku Igaku; 1992 Oct; 29(10):1227-36. PubMed ID: 1464963
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of 99mTc-ethylcysteinate dimer in infarcted brain tissue of rats.
    Inoue Y, Abe O, Kawakami T, Ozaki T, Inoue M, Yokoyama I, Yoshikawa K, Ohtomo K.
    J Nucl Med; 2001 May; 42(5):802-7. PubMed ID: 11337580
    [Abstract] [Full Text] [Related]

  • 13. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping.
    Hyun Y, Lee JS, Rha JH, Lee IK, Ha CK, Lee DS.
    Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclodextrin complexation on the in vivo disposition of the brain imaging radiopharmaceutical 99mTechnetium ethyl cysteinate dimer (99mTc-ECD).
    Oliver DW, Dormehl IC, Louw W, Kilian E, de Beco V, Morretti JL.
    Arzneimittelforschung; 2000 Aug; 50(8):758-64. PubMed ID: 10994161
    [Abstract] [Full Text] [Related]

  • 15. [99mTc-ECD dynamic SPECT in "luxury perfusion" of subacute stroke].
    Ogasawara K, Fujiwara S, Yoshimoto T.
    Kaku Igaku; 1995 Nov; 32(11):1241-7. PubMed ID: 8558792
    [Abstract] [Full Text] [Related]

  • 16. Technetium-99m-ECD brain SPECT in misery perfusion.
    Shimosegawa E, Hatazawa J, Aizawa Y, Shouji Y, Hachiya T, Murakami M.
    J Nucl Med; 1997 May; 38(5):791-6. PubMed ID: 9170448
    [Abstract] [Full Text] [Related]

  • 17. Age-related changes in the cerebral distribution of 99mTc-ECD from infancy to adulthood.
    Kuji I, Sumiya H, Niida Y, Takizawa N, Ikeda E, Tsuji S, Tonami N.
    J Nucl Med; 1999 Nov; 40(11):1818-23. PubMed ID: 10565776
    [Abstract] [Full Text] [Related]

  • 18. Extraction and retention of technetium-99m-ECD in human brain: dynamic SPECT and oxygen-15-water PET studies.
    Ishizu K, Yonekura Y, Magata Y, Okazawa H, Fukuyama H, Tanaka F, Hattori N, Kitano H, Fujita T, Tamaki N, Konishi J.
    J Nucl Med; 1996 Oct; 37(10):1600-4. PubMed ID: 8926507
    [Abstract] [Full Text] [Related]

  • 19. Comparison of reversed phase and reversed phase ion pair high performance liquid chromatography for analysis of TcO and TcN complexes of L,L-ethylene dicysteine di-ethylester and its acid analogues.
    Mang'era KO, Bellande E, Pasqualini R, Verbruggen A.
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1241-4. PubMed ID: 8818040
    [Abstract] [Full Text] [Related]

  • 20. Syntheses and radiolabeling of cysteine-oximes and pharmacological behaviour of their 99mTc complexes.
    Kothari K, Banerjee S, Sarma HD, Pillai MR.
    Appl Radiat Isot; 2000 Jan; 52(1):69-76. PubMed ID: 10670925
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.